Symbols / PSTX
PSTX Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2024-11-07 16:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Poseida Therapeutics, Inc. (PSTX) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance Fri, 13 Dec 2024 08
- Poseida Therapeutics (NASDAQ:PSTX) Stock Skyrockets on News of Roche Holdings Acquisition - Nasdaq ue, 26 Nov 2024 08
- Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc. - PR Newswire ue, 26 Nov 2024 08
- PSTX - Poseida Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan Sun, 06 Sep 2020 05
- Roche Finalizes Poseida Acquisition: This Cell Therapy Deal Feels Like A Win/Win (RHHBY) - Seeking Alpha hu, 09 Jan 2025 08
- Poseida Therapeutics Undergoes Merger and Delisting Changes - Nasdaq Wed, 08 Jan 2025 08
- Roche to Acquire CAR-T Cell Therapy Focused Poseida for $1.5B - Yahoo Finance ue, 26 Nov 2024 08
- Poseida Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for P-BCMA-ALLO1 to Treat Relapsed/Refractory Multiple Myeloma - Stock Titan Mon, 16 Sep 2024 07
- Poseida Therapeutics Stock: Intriguing Buy & Hold Opportunity - Seeking Alpha ue, 07 Feb 2023 08
- Stryker pays $120M in cash for Patient Safety Tech - MassDevice hu, 02 Jan 2014 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for PSTX
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|